anmelden
SMIM
3.118,13
PKT
+4,45
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Swisscom hold | Vontobel Research | |
| 13.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Sonova neutral | Sarasin Research | |
| 13.11.12 | PSP Swiss Property hold | Vontobel Research | |
| 12.11.12 | Swisscom neutral | Nomura | |
| 12.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 12.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 12.11.12 | Swatch (I) buy | Vontobel Research | |
| 12.11.12 | Julius Bär reduce | Vontobel Research | |
| 09.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 09.11.12 | Swisscom neutral | Sarasin Research | |
| 09.11.12 | Swatch (I) buy | Sarasin Research | |
| 09.11.12 | Swisscom hold | Vontobel Research | |
| 08.11.12 | Barry Callebaut neutral | UBS AG | |
| 08.11.12 | Barry Callebaut hold | Société Générale Group S.A. (SG) | |
| 08.11.12 | Swisscom hold | Vontobel Research | |
| 08.11.12 | Barry Callebaut hold | Vontobel Research | |
| 07.11.12 | Sonova equal-weight | Morgan Stanley | |
| 07.11.12 | Barry Callebaut hold | Vontobel Research | |
| 07.11.12 | Adecco SA buy | Vontobel Research | |
| 07.11.12 | Barry Callebaut neutral | Sarasin Research | |
| 07.11.12 | Schindler hold | Vontobel Research | |
| 07.11.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 07.11.12 | Adecco SA neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Avolta (ex Dufry) outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Avolta (ex Dufry) neutral | UBS AG | |
| 06.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Avolta (ex Dufry) underperform | Cheuvreux SA | |
| 06.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 06.11.12 | Adecco SA buy | Sarasin Research | |
| 06.11.12 | Adecco SA buy | Vontobel Research | |
| 05.11.12 | Roche neutral | Citigroup Corp. | |
| 05.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 05.11.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 01.11.12 | Avolta (ex Dufry) outperform | Exane-BNP Paribas SA | |
| 01.11.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 01.11.12 | Schindler hold | Vontobel Research | |
| 01.11.12 | Swisscom hold | Vontobel Research | |
| 01.11.12 | Swisscom neutral | Sarasin Research |
